Editorial Board

Editor-in-Chief

Cynthia L. Sears, MD, FIDSA, is Professor of Medicine, Oncology, and Molecular Microbiology and Immunology at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health and the Microbiome Program Leader of the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Clinically, she focuses on gut infections. She enjoys conducting human translational and bench research stemming from her training as an infectious diseases specialist. Her laboratory focuses on how enteric bacteria and the microbiome promote colon carcinogenesis and modulate cancer immunotherapy responses. She has long been an active member of the Infectious Diseases Society of America, serving as President of IDSA in 2019.

 

Deputy Editors

Cornelius J. (Neil) Clancy, MD, FIDSA, is Tenured Professor of Medicine, Associate Chief of Infectious Diseases and Director of the XDR Pathogen Lab and the Center for Healthcare Mycology at the University of Pittsburgh, and Chief of Infectious Diseases for the VA Pittsburgh Healthcare System. His research lab studies molecular mechanisms of pathogenesis and antimicrobial resistance in Candida spp. and carbapenem-resistant Enterobacteriales. Other research interests include infectious diseases diagnostics, infections in transplant recipients and antimicrobial utilization. Dr. Clancy is chair of the Infectious Diseases Society of America’s committee on treatment guidance for antibiotic-resistant (AMR) Gram-negative infections.

 

Adam Lauring, MD, PhD, FIDSA, is a Professor in the Department of Internal Medicine/Division of Infectious Diseases and the Department of Microbiology & Immunology at the University of Michigan. His research focuses on the genetics and evolution of RNA viruses, and his research group has made contributions to basic, translational, and clinical studies of poliovirus, influenza viruses, and SARS-CoV-2. 

 

 

Jonathan Z. Li, MD, FIDSA, is an Associate Professor of Medicine in the Division of Infectious Diseases at the Brigham and Women’s Hospital and Harvard Medical School. He is the Director of the Harvard/Brigham Virology Specialty Laboratory and the Director of the Harvard University Center for AIDS Research Clinical Core. Dr. Li is the Director of the Virology Core Laboratories for the AIDS Clinical Trials Group (ACTG) and serves as the Vice Chair of the ACTG HIV Reservoirs and Eradication Transformative Science Group.  His research focus is in viral persistence, reservoirs, and drug resistance. Find Dr. Li on X @DrJLi.

Associate Editors

David Andes, MD, FIDSA, is the William A Craig Professor in the Departments of Medicine, Medical Microbiology and Immunology, Head of the Division of Infectious Diseases at the University of Wisconsin, and Director of the Wisconsin Antimicrobial Drug Discovery and Development NIH Center of Excellence. The focus of Dr. Andes’ research program strives to identify strategies to combat antimicrobial drug resistance. His study tactics span from the bench to the clinic, including identifying biofilm resistance mechanisms, drug discovery and development, delineating the optimal dosing strategies for treatment of drug resistant infections using pharmacometric approaches, and clinical trial study of epidemiology and therapy of drug resistance. Find Dr. Andes on X @davidrandes.

 

 Kara W. Chew, MD, MS, is an Associate Professor of Medicine in the Division of Infectious Diseases and Center for Clinical AIDS Research and Education at the University of California, Los Angeles. She is an infectious diseases clinician and clinical translational investigator whose research focuses on clinical trials and leverages antiviral and immune-based interventions to understand mechanisms of disease with acute and chronic viral infections, particularly HIV, hepatitis C, and SARS-CoV-2. She is engaged in the training of investigators in clinical and translational research and serves as Director of the UCLA-CDU Center for AIDS Research Clinical Science Core. She earned a BA and MD through the Program in Liberal Medical Education at Brown University, completed clinical training in internal medicine at University of California, San Francisco, and clinical and research training in infectious diseases at University of California, Los Angeles, where she also earned a Master of Science in Clinical Research.

 

Helen Chu, MD, MPH, FIDSA, is Professor of Medicine, Epidemiology, and Global Health at the University of Washington Schools of Medicine and Public Health. She studies respiratory viruses and vaccines and has conducted clinical trials of vaccines and therapeutics, including maternal flu vaccines in Nepal, SARS-CoV-2 vaccines, and antivirals for treatment of COVID-19 and influenza. As part of the Seattle Flu Study, she designed a prototype pandemic preparedness platform, conducting home-based testing for respiratory viruses with home delivery of antivirals. This study first identified COVID-19 community transmission in the U.S. She serves on NIH and CDC expert working groups in the field of respiratory viruses, maternal immunization, and vaccines. Find Dr. Chu on X @HelenChuMD. 

 

Sara Gianella Weibel, MD, is a Full Professor in the Department of Medicine at the University of California, San Diego (Division of Infectious Diseases and Global Public Health). She earned her MD from the University of Zurich, Switzerland, where she also completed her specialty training in Internal Medicine and Infectious Diseases. She joined the UC San Diego faculty in 2013.

Dr. Gianella leads impactful research at both the UC San Diego Antiviral Research Center and her virology laboratory on campus, where she oversees a dynamic bench research program. She serves as the Director of the Center for AIDS Research (CFAR) Translational Virology Core and the ACTG Virology Specialty Laboratory, contributing to multiple clinical trial protocol teams. She also co-directs the NeuroVirology and Biology Core at the HIV Neurobehavioral Research Center and the HOPE T32 Training Program. A clinical and translational virologist, Dr. Gianella specializes in molecular biology and immunology. Her research emphasizes inclusivity and health equity, with a particular focus on studies involving women, transgender individuals, and other underrepresented populations. Her dedication extends beyond the lab, as she actively mentors the next generation of physician-scientists.

Audrey Odom John, MD, PhD, is Professor of Pediatrics and Microbiology at the University of Pennsylvania and Chief of the Division of Infectious Diseases at the Children’s Hospital of Philadelphia. Dr. John’s research interests include antimalarial and antistaphylococcal drug discovery and diagnostics for pediatric infectious diseases. Find Dr. John on X @odomjohnlab.

 

 

 

Daniel T. Leung, MD, MSc, FIDSA, FASTMH, is Professor of Internal Medicine and the Dr. Thomas D. Rees and Natalie B. Rees Presidential Endowed Chair in Global Medicine at the University of Utah. His research group focuses on the immunology, microbiology, and clinical management of diarrheal diseases and other mucosal infections, working in collaboration with investigators in Bangladesh, Cameroon, Democratic Republic of Congo, Mali, Tanzania, and the USA.

 

 

 

Joseph Lewnard, PhD is an Associate Professor of Epidemiology at the University of California, Berkeley with joint appointments in Computational Biology and Computational Precision Health. He leads studies of the epidemiology, transmission dynamics, and natural history of vaccine-preventable pathogens as well as postlicensure studies of vaccine effectiveness. With colleagues at Kaiser Permanente Southern California, he co-leads one of five Centers for Innovation in CDC's InsightNet National Outbreak Analytics & Disease Modeling Network, as well as the California Emerging Infections Program in conjunction with the California Department of Public Health.

 

 

Anita K. McElroy, MD PhD is a tenured Associate Professor of Pediatrics at the University of Pittsburgh in the division of Infectious Diseases. Clinically, she serves on the Pediatric Infectious Disease Team and provides care for patients with osteomyelitis, complicated pneumonia, Lyme disease and other infectious disease diagnoses. Her research interests include emerging arthropod borne viruses and hemorrhagic fever viruses. Her lab focuses on host-pathogen interactions including understanding the role of host heterogeneity and viral tropism in modulating viral pathogenesis and on defining immune correlates of protection from disease. Find Dr. McElroy @fablabpitt.bsky.social.

 

 

Igho Ofotokun, MD, MSc, FIDSA, is a tenured Professor of Medicine at Emory University School of Medicine and Professor of Behavioral Sciences and Health Education at Emory University Rollins School of Public Health. He is a Staff Physician at Grady Memorial Health System, the Associate Division Director for Research, Emory University Infectious Diseases Division, and the Co-Director of the Emory Center for AIDS Research Clinical Core. He has served on the membership and/or leadership of several high-profile national and international committees, including the FDA Antimicrobial Drugs Advisory Committee, the Infectious Diseases Society of America Board of Directors, the HIV Medicine Association Board of Directors, as chair on an NIH Study Section, the inaugural chair of the HIVMA Leadership Development Committee, the Taskforce for COVID-19 Vaccine, Nigeria Governors Forum, and the IDSA Leadership Institute Working Group.

 

Roger Paredes, MD, PhD, is Head of the Department of Infectious Diseases at the Hospital Germans Trias i Pujol and Principal Investigator at the irsiCaixa AIDS Research Institute in Badalona, Catalonia, Spain. His research interests focus on COVID-19 and HIV therapeutics, drug resistance, and the role of the human microbiome in HIV cure. Find Dr. Paredes on X at @RutgerWalls.

 

 

 

Irini Sereti, MD, is the Chief of the Laboratory of Immunoregulation and and Infectious Diseases at the U.S. National Institute of Allergy and Infectious Diseases of the National Institutes of Health. She is a physician-scientist, with research that focuses on the immunological aspects of HIV and idiopathic CD4 lymphopenia and the pathogenesis and management of opportunistic infections and non-infectious complications in people with HIV. She is dedicated to promoting women in biomedical sciences and bridging immunology with infectious diseases. Find Dr. Sereti on Bluesky at @irinisereti.bsky.social. 

*Dr. Sereti is serving in her personal capacity.

 

Kathryn E. Stephenson, MD, MPH, is an Associate Professor of Medicine in the Division of Infectious Diseases and the Center for Vaccine and Virology Research at Beth Israel Deaconess Medical Center and Harvard Medical School. She designs and conducts clinical trials testing novel immunologic interventions for HIV and emerging infectious diseases, with a particular emphasis on vaccine development. She is a member of the US HIV Vaccine Trials Network Scientific Governance Committee and is Principal Investigator and Protocol Chair of multiple first-in-human, phase 1 vaccine clinical trials for HIV, Zika virus and COVID-19. Recently, she has expanded her research into large scale observational studies of respiratory virus epidemiology, investigating the impact of vaccination on the transmission of respiratory viruses like influenza, RSV and SARS-CoV-2. Find Dr. Stephenson at https://research.bidmc.org/kathryn-stephenson.

 

Jeffrey A. Tornheim, MD, MPH, is an Associate Professor of Medicine, Pediatrics, and International Health at the Johns Hopkins University School of Medicine as well as a TB clinician at the Baltimore City Health Department. His research is focused on tuberculosis diagnostics, resistance detection, pharmacology, next generation sequencing, biomarkers of treatment response, and personalized therapy for drug resistant infections. 

 

 

 

Anne-Catrin Uhlemann, MD, PhD, FIDSA, is a tenured Associate Professor of Medicine in the Division of Infectious Diseases at Columbia University Irving Medical Center, where she is also Director of the Microbiome & Pathogen Genomics Collaborative Center. Her research interests include the molecular evolution and adaptation of bacterial pathogens and mechanisms of antimicrobial resistance in Enterobacterales as well as the contribution of the microbiome to infections, health, and disease.

 

Statistical Editors

Elizabeth Brown, Sc. D. is a Professor in the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center and a Research Professor of Biostatistics at University of Washington. Her research interests include design and analysis of infectious disease clinical trials and statistical modeling of susceptibility and transmission.

 

 

 

Michael D. Hughes, Ph.D. is a Professor of Biostatistics and Director of the Center for Biostatistics in AIDS Research at the Harvard T.H. Chan School of Public Health. His statistical research focuses on the design and analysis of clinical trials and observational studies in infectious diseases research. He directs the statistical center for the ACTG (Advancing Clinical Therapeutics Globally for HIV and Other Infections clinical trials network) and collaborates extensively on clinical research on the treatment and prevention of infectious diseases.

 

C. Christina Mehta, PhD, MSPH, is an Associate Professor of Medicine in the Division of Infectious Diseases and the Director of Infectious Diseases Biostatistics in the Emory University School of Medicine. Her research interest is in the design and analysis of observational cohort studies, and she collaborates extensively with clinical and translational infectious disease researchers.

 

 

 

Erica E. M. Moodie, PhD, is a Professor of Biostatistics at McGill University. Her research interests are in causal inference and longitudinal data with a particular focus on statistical methodology for precision medicine.

 

 

 

Associate Editor for Supplements

Anne Piantadosi MD, PhD is an Assistant Professor in the Emory University School of Medicine, Department of Pathology and Laboratory Medicine and Department of Medicine, Division of Infectious Diseases. Her research is focused on the emergence and evolution of viruses of clinical and public health importance, and her group uses a combination of translational, laboratory, and computational approaches. She has clinical interest in central nervous system infections.

 

 

 

Methodological Editor

Jean-Jacques Parienti, MD, PhD, is a Professor of Medicine at Caen University Hospital, France. Dr. Parienti leads the Clinical Research Department as Medical Director. Dr. Parienti cares for outpatient people with HIV at the Infectious Diseases Department and helps investigators with their research design and analysis at the Methodological and Statistic platform. Dr. Parienti’s topics of research include antiretroviral therapies, biomarker-driven antibiotic stewardship, healthcare-associated infections and public health interventions to mitigate emerging infectious diseases. Find Dr. Parienti on X at @JjParienti and on Bluesky @JjParienti.bsky.social.

 

 

Managing Editor

Ande Rosado

[email protected]

Contact for Research Integrity and Publication Ethics Questions

Assistant Managing Editor

Swanson Tudor

Supplements Specialist

Kiley Mead

Past Editors

1904-1936 Ludvig Hektoen & Edwin O. Jordan (Volumes 1-59)

1937-1940 Ludvig Hektoen & William H. Taliaferro (Volumes 60-67)

1941-1957 William H. Taliaferro (Volumes 68-100)

1957-1960 William H. Taliaferro & James W. Moulder (Volumes 101-106)

1960-1968 James W. Moulder (Volumes 107-118)

1969-1979 Edward H. Kass (Volumes 119-139)

1979-1983 George Gee Jackson (Volumes 140-148)

1984-1988 Martha Yow (Volumes 149-158)

1989-2002 Marvin Turck (Volumes 159-186)

2003-2022 Martin S. Hirsch (Volumes 187-226)

Editorial Advisory Board

Lee-Ann Allen, Coralville, Iowa

Robert L. Atmar, Houston, Texas

Jennifer Balkus, Seattle, Washington

Rui Bao, Chengdu, China

Buddha Basnyat, Kathmandu, Nepal

Luiz Bermudez, Corvallis, Oregon

Samuel J. Black, Amherst, Massachusetts

Henry C. Bodenheimer, New York, New York

Louis Bont, Utrecht, The Netherlands

William Britt, Birmingham, Alabama

Jeremy Brown, London, United Kingdom

Pedro Cahn, Buenos Aires, Argentina

Angela Caliendo, Providence, Rhode Island

Juan J. Calix, Birmingham, Alabama

Agostinho Carvalho, Braga, Portugal

Arturo Casadevall, Bronx, New York

Richelle Charles, Boston, Massachusetts

Limin Chen, Toronto, Canada/Chengdu, China

Helen Y. Chu, Seattle, Washington

Steven J. Clipman, Baltimore, Maryland

Jeffrey Cohen, Bethesda, Maryland

Myron S. Cohen, Chapel Hill, North Carolina

Andrea M. Cooper, Saranac Lake, New York

Philip J. Cooper, Quito, Ecuador

Benjamin Cowling, Pokfulam, Hong Kong

Eric S. Daar, Los Angeles, California

Johanna P. Daily, Bronx, New York

George Deepe, Jr., Cincinnati, Ohio

Hazel M. Dockrell, London, United Kingdom

Ann Falsey, Rochester, New York

Daniel Fierer, New York, New York

Kenneth Fife, Indianapolis, Indiana

Ron Fouchier, Rotterdam, the Netherlands

Thomas W. Geisbert, Galveston, Texas

Anne A. Gershon, New York, New York

Bradford Gessner, Anchorage, Alaska and Paris, France

Varduhi Ghazaryan, Bethesda, Maryland

Andreas H. Groll, Muenster, Germany

Huldrych Günthard, Zürich, Switzerland

David W. Haas, Nashville, Tennessee

Anders Hakansson, Buffalo, New York

Natasha Halasa, Nashville, TN

Thomas R. Hawn, Seattle, Washington

Frederick G. Hayden, Charlottesville, Virginia

Mary Hensler, San Diego, California

Lisa Hirschhorn, Boston, Massachusetts

Ya-Chi Ho, New Haven, Connecticut

Michael Holbrook, Bethesda, Maryland

Peter Hunt, San Francisco, California

Michael G. Ison, Chicago, Illinois

Mamta Jain, Dallas, Texas

Hanna Jarva, Helsinki, Finland

Stephanie Jost, Durham, NC

Jia-Horng Kao, Taipei, Taiwan

Petros C. Karakousis, Baltimore, Maryland

Anu Kauppinen, Kuopio, Finland

Kenneth Kaye, Boston, Massachusetts

Arthur Y. Kim, Boston, Massachusetts

Paul Klenerman, Oxford, United Kingdom

Dimitrios Kontoyiannis, Houston, Texas

Shyam Kottilil, Bethesda, Maryland

Benjamin M. Liu, Washington DC

Per Ljungman, Stockholm, Sweden

Shabir Madhi, Gauteng, South Africa

David Margolis, Chapel Hill, North Carolina

Jeanne Marrazzo, Seattle, Washington

Esteban Martinez, Barcelona, Spain

Joel Maslow, Philadelphia, Pennsylvania

M. Catherine McEllistrem, Pittsburgh, Pennsylvania

Gregory J. Mertz, Albuquerque, New Mexico

David Mesher, London, United Kingdom

Edward S. Mocarski, Palo Alto, California

Arnold Monto, Ann Arbor, Michigan

Ank Nijhawan, Dallas, Texas

Joshua D. Nosanchuk, Bronx, New York

David O'Callaghan, Nimes, France

Pedro Piedra, Houston, Texas

Ligia Pinto, Frederick, Maryland

Liise-ann Pirofski, Bronx, New York

Stanley A. Plotkin, Doylestown, Pennsylvania

David A. Price, Bethesda, Maryland

Alice S. Prince, New York, New York

Thomas C. Quinn, Baltimore, Maryland

Justin D. Radolf, Farmington, Connecticut

Octavio Ramilo, Columbus, Ohio

Jennifer Read, Washington, DC

Amariliz Rivera-Medina, Newark, New Jersey

Stephen J. Rogerson, Melbourne, Australia

Philip J. Rosenthal, San Francisco, California

Leah Rubin, Baltimore, Maryland

Caroline Sabin, London, United Kingdom

Jagannadha Sastry, Houston, Texas

Erwin Schurr, Montreal, Canada

Mark Siedner, Boston, Massachusetts

Scott Sieg, Cleveland, Ohio

Margaret Stanley, Cambridge, United Kingdom

Jack T. Stapleton, Iowa City, Iowa

Allen C. Steere, Boston, Massachusetts

Eike Steinmann, Bochum, Germany

Philip E. Tarr, Bruderholz, Switzerland

Phillip I. Tarr, St. Louis, Missouri

David L. Thomas, Baltimore, Maryland

Cécile Tremblay, Montreal, Canada

Anna Wald, Seattle, Washington

Robert Wallis, Washington, DC

Ronald G. Washburn, Charleston, South Carolina

Heiner Wedemeyer, Hannover, Germany

Ming-Lung Yu, Kaohsiung, Taiwan